Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Interaction of Anti-Yo and anti-Hu Antibodies with Neurons in Living Mice Following Intracranial Injection or Infusion: Demonstration of Neuronal Antibody Uptake and Early Detection of Neuronal Death
Autoimmune Neurology
S41 - Autoimmune Neurology 3: Autoimmune Encephalitis, Paraneoplastic Neurologic Disorders, Antibody-Mediated Diseases, Immunology (4:06 PM-4:18 PM)
004

Anti-Yo and anti-Hu are autoantibodies associated with syndromes of paraneoplastic neuronal destruction in the setting of gynecological or breast carcinomas (anti-Yo) or small cell lung cancer (anti-Hu).  The roles of these two antibodies in causing neuronal death is uncertain: although both antibodies have been shown to cause neuronal death in rodent brain slice cultures, production of neuronal death by these antibodies has never been demonstrated in living animals.

 

1) To determine whether anti-Yo and anti-Hu antibodies are taken up by neurons and cause neuronal death in living animals, as has been shown to occur in rodent brain slice cultures.  2) To determine whether methods of detecting neuronal death in slice culture can be used to study brains of animals following antibody infusion.

Mice were injected intraventricularly with anti-Hu antibodies and sacrificed at 72 hours.  In subsequent studies, mice were implanted with Alzet osmotic pumps and infused intraventricularly with anti-Yo or anti-Hu antibodies over a period of 2 weeks.  Cerebellar slice cultures prepared from brains of treated and control animals were incubated with SYTOX dyes to detect cell death, fixed, and labeled with Cy5-conjugated anti-human IgG to detect antibody uptake.

Neuronal uptake of anti-Hu antibodies was demonstrated in slice cultures prepared from animals injected intraventricularly.  Uptake of both anti-Yo and anti-Hu antibodies was demonstrated in animals infused using Alzet pumps.  In both sets of experiments, antibody uptake was accompanied by focal neuronal death as indicated by staining with SYTOX dyes.

Anti-Hu and anti-Yo antibodies can be taken up by neurons in living animals, as has been previously demonstrated in rodent brain slice cultures.  Both antibodies can cause neuronal death without immunization to induce a specific T cell response.  These findings support a direct role for anti-Yo and anti-Hu antibodies in causing paraneoplastic neuronal injury.

 

Authors/Disclosures
Tammy L. Smith, MD, PhD (Imaging and Neurosciences Center)
PRESENTER
The institution of Dr. Smith has received research support from Alexion/AstraZeneca. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a attendee with Euroimmun Academy for travel support only.
Daniel R. Scoles, PhD, FAAN (University of Utah) The institution of Dr. Scoles has received research support from NIH.
Noel Carlson, PhD (VA SLC HCS) The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Stacey Clardy, MD, PhD, FAAN (University of Utah) Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
John E. Greenlee, MD, FAAN (University of Utah) Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.